Global Peritoneal Dialysis Market

Global Peritoneal Dialysis Market Size, Share, Growth Analysis, By Product Type(CAPD, APD), By Product(Cyclers, Fluids), By End User(Home Health Care, Hospitals) - Industry Forecast 2024-2031


Report ID: SQMIG35D2183 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 87 | Figures: 77

Global Peritoneal Dialysis Market Regional Insights

With a market share of more than 35.0 percent and the highest revenue in 2021, North America dominated the global peritoneal dialysis market. The region's market is expanding as a result of the existence of important players, large government expenditures in the creation of cutting-edge medical devices, and a favorable reimbursement environment. Dialysis is becoming more popular as a result of the increase in kidney failures and chronic kidney diseases (CKD). High disposable income, government efforts, and rising healthcare spending are a few major reasons boosting the industry.

For example, 37 million US adults, or 15 percent of the population, or more than one in seven are thought to have CKD. Up to 90% of persons with CKD are unaware of their condition. Nearly 25% of persons with severe CKD are unaware of their condition. CKD is more prevalent in those over the age of 65 (38%) compared to those between the ages of 45 and 64 (12%) and 18 to 44 (44%) (6 percent). Women are significantly more often than males (14%) to have CKD (12 percent). Approximately 14% of adult Hispanics have CKD.

Over the projected period, the Asia Pacific region is anticipated to have the greatest CAGR, at 7.6%. Rising renal failure cases, an aging population, and increased product development are anticipated to fuel market expansion over the course of the projected period. For example, the frequency of both general and advanced CKD varied significantly. In Asia, there are up to 434.3 million individuals with CKD, up to 65.6 million of whom have advanced CKD. The countries with the highest numbers of people with CKD were China (up to 159.8 million) and India (up to 140.2 million), which together accounted for 69.1 percent of all adults with CKD in the area. In addition, the IDF estimates that 88 million individuals in South East Asia already have diabetes, with 153 million likely to have the disease by 2045. In addition, increased government efforts, CKD awareness programs, technologically advanced goods, the availability of newly built, state-of-the-art healthcare facilities in the area, and rising healthcare spending are a few additional factors influencing the global peritoneal dialysis market growth.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Peritoneal Dialysis Market size was valued at USD 76.9 billion in 2019 and is poised to grow from USD 81.8 billion in 2023 to USD 126.43 billion by 2031, growing at a CAGR of 6.4% in the forecast period (2024-2031).

The global peritoneal dialysis market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For example, to enhance the patient treatment experience and for better overall results, Medtronic, a pioneer in healthcare technology, has partnered with DaVita's extensive experience as a provider of comprehensive kidney care. Together, they plan to establish a new independent medical device company called "NewCo," with a focus on kidneys. For patients with renal failure, NewCo will be positioned as an advanced firm of discovery and distinctive therapeutics. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. ' Baxter B. Braun Melsungen AG Fresenius Medical Care AG & Co. KGaA Medtronic plc Terumo Corporation Cook Medical Inc. Utah Medical Products Inc. Cardinal Health Inc. Poly Medicure Limited Diversified Specialty Institute Holdings Inc. Renax Biomedical Tech Co. Ltd. Renal Solutions Inc. Vygon SA Merit Medical Systems Inc. Huaren Pharmaceutical Co. Ltd. Nikkiso Co. Ltd. Nephros Inc. Covidien plc AngioDynamics Inc. Q Core Medical Ltd. ', 'Baxter', 'B. Braun Melsungen AG', 'Fresenius Medical Care AG & Co. KGaA', 'Medtronic plc', 'Terumo Corporation', 'Cook Medical Inc.', 'Utah Medical Products Inc.', 'Cardinal Health Inc.', 'Poly Medicure Limited', 'Diversified Specialty Institute Holdings Inc.', 'Renax Biomedical Tech Co. Ltd.', 'Renal Solutions Inc.', 'Vygon SA', 'Merit Medical Systems Inc.', 'Huaren Pharmaceutical Co. Ltd.', 'Nikkiso Co. Ltd.', 'Nephros Inc.', 'Covidien plc', 'AngioDynamics Inc.', 'Q Core Medical Ltd.'

During the projected period, factors like rising end-stage renal disease (ESRD) prevalence, technical advancements in peritoneal dialysis cyclers, and rising demand for home dialysis treatment is anticipated to propel the growth of the peritoneal dialysis market. Peritoneal dialysis also has several benefits, including lower costs compared to hemodialysis, needle-free therapy, mobility, ease of treatment, and fewer dietary restrictions, which all contribute to the market's expansion internationally.

The primary growth drivers of the global peritoneal dialysis market are increase in the prevalence of End Stage Renal Disease (ESRD), increase in the number of patients with acute diabetes and high blood pressure, increased public awareness of peritoneal dialysis, increased government initiatives globally, and an increase in the demand for technologically advanced treatment methods. Additionally, growing peritoneal dialysis use in developing nations like China, India, and others would open up new prospects for the global peritoneal dialysis market.

With a market share of more than 35.0 percent and the highest revenue in 2021, North America dominated the global peritoneal dialysis market. The region's market is expanding as a result of the existence of important players, large government expenditures in the creation of cutting-edge medical devices, and a favorable reimbursement environment. Dialysis is becoming more popular as a result of the increase in kidney failures and chronic kidney diseases (CKD). High disposable income, government efforts, and rising healthcare spending are a few major reasons boosting the industry.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Peritoneal Dialysis Market

Product ID: SQMIG35D2183

$5,300
BUY NOW GET FREE SAMPLE